Cart (0 Items)
Your cart is currently empty.
View Products
              
              
              
              | Size | 100ug, 1MG  | 
		
|---|---|
| Isotype | IgG1, kappa  | 
		
| Brand | ProteoGenix  | 
		
| Product type | Primary Antibodies  | 
		
| Clonality | Monoclonal Antibody  | 
		
| Expression system | Mammalian cells  | 
		
| Applications | Elisa, WB  | 
		
| Product name | Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb - Research Grade | 
|---|---|
| Source | CAS 1393344-72-3 | 
| Species | Homo sapiens | 
| Expression system | Mammalian cells | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Varlilumab,1F5,CDX-1127,CD27, TNFRSF7,anti-CD27, TNFRSF7 | 
| Reference | PX-TA1352 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG1-kappa | 
| Clonality | Monoclonal Antibody | 
Varlilumab has been investigated for the treatment of Melanoma, Skin Ulcer, Burkett’s Lymphoma, Mantle cell lymphoma, and T-cell Malignancy.
                Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.